Patient-centred assessment of COPD in primary care: Experience from a cross-sectional study of health-related quality of life in Europe

Primary Care Respiratory Journal

Volumn 21, Issue 3, 2012, Pages 329-336

  Jones, Paul W ^a   Brusselle, Guy ^b   Dal Negro, Roberto W ^c   Ferrer, Montse ^d,e   Kardos, Peter ^f   Levy, Mark L ^g   Perez, Thierry ^h   Cataluña, Juan José Soler ⁱ   van der Molen, Thys ^j   Adamek, Lukasz ^k   Banik, Norbert ^l  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Orlandi General Hospital   (Italy)

^d HOSPITAL DEL MAR   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f Maingau Hospital   (Germany)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k GLAXOSMITHKLINE   (United Kingdom)

^l GLAXOSMITHKLINE   (Germany)

more..

Author keywords

COPD; Cross sectional; Europe; Health related quality of life; HEED; Primary care

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTITIONER; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE CLASSIFICATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE SCORE; SCORING SYSTEM; SELF REPORT; SPIROMETRY;

AGED; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84866488721     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00065     Document Type: Article

References (37)

1. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27:188-207. http://dx.doi.org/10.1183/09031936.06.00024505
2. The Global Initiative for Chronic Obstructive Lung disease (GOLD) revised 2009; www.goldcopd.com.
3. Bellamy D, Bouchard J, Henrichsen S, et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2006;15:48-57. http://dx.doi.org/10.1016/j.pcrj.2005.11.003
4. Sobradillo-Pena V, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000;118:981-9. http://dx.doi.org/10.1378/chest.118.4.981
5. Frank TL, Hazell ML, Linehan MF, Morris JA, Frank PI. The estimated prevalence of chronic obstructive pulmonary disease in a general practice population. Prim Care Respir J 2007;16:169-73. http://dx.doi.org/10.3132/pcrj.2007.00028
6. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004;9:458-65. http://dx.doi.org/10.1111/j.1440-1843.2004.00637.x
7. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000;117(Suppl 2):354S-9S. http://dx.doi.org/10.1378/chest.117.5_suppl_2.354S
8. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):181-72.
9. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. http://dx.doi.org/10.1183/09031936.04.00014304
10. Buist S. COPD: a common disease that is preventable and treatable. Prim Care Respir J 2006;15:7-9. http://dx.doi.org/10.1016/j.pcrj.2005.12.004
11. Cazzola M, MacNee W, Martinez FJ, et al. on behalf of the American Thoracic Society/European Respiratory Society Task Force on outcomes of COPD. Outcomes of COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-69. http://dx.doi.org/10.1183/09031936.00099306
12. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992;5:659-64.
13. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-9.
14. Gruffydd-Jones K. A national strategy for the management of chronic obstructive pulmonary disease (COPD) in England: aiming to improve the quality of care for patients. Prim Care Respir J 2008;17(Suppl 1):S1-S8. http://dx.doi.org/10.3132/pcrj.2008.00071
15. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med 2011;9:7. http://dx.doi.org/10.1186/1741-7015-9-7
16. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. http://dx.doi.org/10.1016/S0140-6736(07)61377-4
17. Menezes AM, Perez-Padilla R, Jardim JR, et al. PLATINO team: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81. http://dx.doi.org/10.1016/S0140-6736(05)67632-5
18. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011;1:57-66. http://dx.doi.org/10.1016/j.rmed.2010.09.004
19. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved COPD specific version of the St. George Respiratory Questionnaire. Chest 2007;132:456-63. http://dx.doi.org/10.1378/chest.06-0702
20. Ware JE, Kosinski M, Keller SD. A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33. http://dx.doi.org/10.1097/00005650-199603000-00003
21. Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54. http://dx.doi.org/10.1183/09031936.00102509
22. Webster K., Odom L, Peterman A, Lent L, Cella D. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version 4 of the core questionnaire. Qual Life Res 1999;8(7):604.
23. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6. http://dx.doi.org/10.1136/thx.54.7.581
24. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011;38:29-35. http://dx.doi.org/10.1183/09031936.00177210
25. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863-8 http://dx.doi.org/10.1136/thx.2009.115725.
26. van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J 2003;21:16s-22s. http://dx.doi.org/10.1183/09031936.03.00040403
27. Norrhall MF, Nilsfelt A, Varas E, et al. A feasible lifestyle program for early intervention in patients with chronic obstructive pulmonary disease (COPD): a pilot study in primary care. Prim Care Respir J 2009;18(4):306-12. http://dx.doi.org/10.4104/pcrj.2009.00041
28. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869-73. http://dx.doi.org/10.1136/thx.2006.059071
29. Wilt TJ, Niewoehner D, Kim C, et al. Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD). Summary, Evidence Report/Technology Assessment: Number 121. AHRQ Publication Number 05-E017-1, August 2005. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/spirosum.htm
30. Puhan MA, Vollenweider D, Latsgang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res 2007;8:30. http://dx.doi.org/10.1186/1465-9921-8-30
31. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD. A systematic review and metaanalysis. Chest 2008;133:756-66. http://dx.doi.org/10.1378/chest.07-1207
32. Ferrer M, Villasante C, Alonso J, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002;19:405-13.
33. Carrasco-Garrido P, de Miguel-Diez J, Rejas-Gutierrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients: results of the EPIDEPOC study. Health Qual Life Outcomes 2006;4:31.
34. Carrasco-Garrido P, de Miguel-Diez J, Rejas-Gutierrez J, et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 2009;9:2. http://dx.doi.org/10.1186/1471-2466-9-2
35. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63:402-07. http://dx.doi.org/10.1136/thx.2007.085456
36. Izquierdo JL, Barcina C, Jimenez J, Munoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract 2009;63:87-97. http://dx.doi.org/10.1111/j.1742-1241.2008.01936.x
37. Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Molken MP. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006;100:83-6. http://dx.doi.org/10.1016/j.rmed.2005.04.004